Glucose sensor health monitoring and related methods and systems
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G05B-023/00
A61M-005/172
A61M-005/142
출원번호
US-0281773
(2014-05-19)
등록번호
US-10152049
(2018-12-11)
발명자
/ 주소
Nogueira, Keith
Li, Xiaolong
Shah, Rajiv
Kannard, Brian T.
출원인 / 주소
MEDTRONIC MINIMED, INC.
대리인 / 주소
Lorenz & Kopf, LLP
인용정보
피인용 횟수 :
0인용 특허 :
198
초록▼
Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a user involves determining one or more signal characteristics associated with a subset of the measurements corresponding to a monitoring
Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a user involves determining one or more signal characteristics associated with a subset of the measurements corresponding to a monitoring period, determining a reliability metric for the monitoring period based on the one or more signal characteristics, and providing indication of a maintenance condition when the reliability metric violates a threshold.
대표청구항▼
1. A method of providing indication when replacement of an interstitial glucose sensing element of a sensing arrangement should be performed in connection with operating an infusion device operable to deliver fluid to a user based on measurements indicative of an interstitial fluid glucose level of
1. A method of providing indication when replacement of an interstitial glucose sensing element of a sensing arrangement should be performed in connection with operating an infusion device operable to deliver fluid to a user based on measurements indicative of an interstitial fluid glucose level of the user provided by the sensing arrangement, the fluid influencing the physiological condition of the user, the method comprising: obtaining, by a control module coupled to the interstitial glucose sensing element of the sensing arrangement, a plurality of uncalibrated measurements corresponding to a monitoring period based on output signals provided by the sensing element, wherein the output signals are influenced by the interstitial fluid glucose level of the user;obtaining, by the control module, a calibration factor for converting the plurality of uncalibrated measurements to a plurality of calibrated measurement values for the physiological condition;for each respective measurement of the plurality of uncalibrated measurements: determining a second derivative metric associated with the respective measurement based at least in part on a difference between a first derivative metric associated with the respective measurement and the first derivative metric associated with the preceding measurement of the plurality of uncalibrated measurements, wherein the second derivative metric associated with a most recent measurement of the plurality of uncalibrated measurements comprises the greater of a difference between the first derivative metric associated with the most recent measurement and the first derivative metric associated with the immediately preceding measurement of the plurality of uncalibrated measurements and an average magnitude of second derivative metric values associated with the plurality of uncalibrated measurements; andscaling the second derivative metric associated with the respective measurement by the calibration factor to determine a noise metric for the respective measurement of the plurality of uncalibrated measurements;determining, by the control module, a number of high noise measurements for the monitoring period based on the noise metrics for the respective measurements of the plurality of uncalibrated measurements;determining, by the control module, an output measurement value indicative of the interstitial fluid glucose level based at least in part on the most recent measurement of the plurality of uncalibrated measurements and at least one of the first derivative metric associated with the most recent measurement and the second derivative metric associated with the most recent measurement;transmitting, by a communications interface coupled to the control module, the output measurement value to the infusion device, wherein a delivery command for operating a motor of the infusion device to autonomously control delivery of the fluid to the user is determined based at least in part on the output measurement value and the calibration factor; andproviding, via an output interface of the sensing arrangement, indication replacement of the interstitial glucose sensing element should be performed when a reliability metric influenced by the number of high noise measurements violates a first threshold. 2. The method of claim 1, further comprising determining a number of consecutive monitoring periods that violated the first threshold when the number of high noise measurements for the monitoring period violates the first threshold, wherein providing the indication comprises automatically providing the indication when the number of consecutive monitoring periods is greater than a second threshold. 3. The method of claim 1, further comprising: determining an average measurement value for the monitoring period based on the plurality of uncalibrated measurements; and determining the reliability metric based at least in part on a ratio of the average measurement value to the number of high noise measurements. 4. The method of claim 3, further comprising determining a second number of consecutive monitoring periods that violated the first threshold when the reliability metric for the monitoring period violates the first threshold, wherein providing the indication comprises providing the indication when the second number of consecutive monitoring periods is greater than a second threshold. 5. The method of claim 1, wherein determining the number of high noise measurements comprises determining the number of respective measurements of the plurality of uncalibrated measurements having an associated noise metric greater than a threshold value. 6. The method of claim 5, further comprising determining a second number of consecutive monitoring periods that violated the first threshold when the reliability metric for the monitoring period violates the first threshold, wherein providing the indication comprises providing the indication when the second number of consecutive monitoring periods is greater than a second threshold. 7. A non-transitory computer-readable medium having computer-executable instructions stored thereon that, when executed by the control module, cause the control module to perform the method of claim 1. 8. The method of claim 1, further comprising: periodically sampling the output signals of the interstitial glucose sensing element to obtain a plurality of unfiltered measurement values stored in an unfiltered sample buffer;periodically obtaining a plurality of unfiltered measurement values from the unfiltered sample buffer;applying a filter to the plurality of uncalibrated measurements to obtain a filtered measurement; andstoring the filtered measurement in a filtered sample buffer, wherein obtaining, the plurality of uncalibrated measurements corresponding to the monitoring period comprises obtaining the plurality of uncalibrated measurements from the filtered sample buffer. 9. The method of claim 1, wherein obtaining the plurality of uncalibrated measurements comprises obtaining a plurality of five-minute filtered measurement values. 10. The method of claim 9, further comprising: periodically sampling the output signals of the interstitial glucose sensing element on a per-minute to obtain a plurality of unfiltered measurement values stored in an unfiltered sample buffer; andperiodically obtaining the plurality of unfiltered measurement values from the unfiltered sample buffer every five minutes;applying a filter to the plurality of unfiltered measurement values obtained from the unfiltered sample buffer to obtain the respective five-minute filtered measurement values of the plurality of five-minute filtered measurement values. 11. The method of claim 10, wherein the first derivative metric associated with each respective measurement of the plurality of uncalibrated measurements comprises a difference between a respective five-minute filtered measurement value and an immediately preceding five-minute filtered measurement value. 12. The method of claim 11, further comprising: converting the most recent measurement into a sensed glucose value using the calibration factor; anddetermining the delivery command for operating the motor of the infusion device to deliver the fluid to the user based at least in part on the sensed glucose value. 13. The method of claim 1, wherein determining the delivery command comprises: converting the most recent measurement into a sensed glucose value using the calibration factor; anddetermining an insulin dosage command based at least in part on a difference between the sensed glucose value and a target glucose value. 14. The method of claim 13, further comprising operating the motor of the infusion device to achieve the insulin dosage command. 15. An infusion system providing indication when replacement of an interstitial glucose sensing element should be performed, the interstitial glucose sensing element providing output signals influenced by an interstitial fluid glucose level in a body of a user, the infusion system comprising: a communications interface; anda control module coupled to the interstitial glucose sensing element and the communications interface to determine a plurality of uncalibrated filtered measurements based on the output signals, determine one or more noise metrics associated with a subset of the plurality of uncalibrated filtered measurements corresponding to a monitoring period based at least in part on a calibration factor for converting the plurality of uncalibrated filtered measurements to a plurality of calibrated measurement values for the physiological condition, determine a reliability metric for the monitoring period based on the one or more noise metrics, determine an output measurement value indicative of the interstitial fluid glucose level based at least in part on a most recent measurement of the subset and at least one of a first derivative metric associated with the most recent measurement and a second derivative metric associated with the most recent measurement, transmit the output measurement value to an infusion device via the communications interface, and provide indication for replacement of the sensing element when the reliability metric violates a first threshold, wherein: a delivery command for operating a motor of the infusion device to autonomously control delivery of a fluid influencing the interstitial fluid glucose level to the user is determined based at least in part on the output measurement value and the calibration factor;the one or more noise metrics comprise a respective noise metric for each respective uncalibrated filtered measurement of the subset and an average measurement value of the subset of the plurality of uncalibrated filtered measurements for the monitoring period;the respective noise metric for each respective uncalibrated filtered measurement comprises a second derivative metric associated with the respective uncalibrated filtered measurement scaled by the calibration factor;the second derivative metric associated with the most recent measurement of the subset comprises the greater of a difference between the first derivative metric associated with the most recent measurement and the first derivative metric associated with an immediately preceding measurement of the subset and an average magnitude of the second derivative metric values associated with the subset;the reliability metric comprises a ratio of the average measurement value to a number of high noise measurements over the monitoring period; andthe number of high noise measurements comprises a number of filtered measurements of the subset having respective noise metrics that violate a second threshold. 16. The infusion system of claim 15, further comprising an output user interface element coupled to the control module, wherein providing the indication comprises the control module generating a user notification indicating replacement of the sensing element when the reliability metric violates the first threshold. 17. The infusion system of claim 15, wherein the control module determines a second number of consecutive monitoring periods that violated the first threshold when the reliability metric for the monitoring period violates the first threshold and automatically provides the indication when the second number of consecutive monitoring periods is greater than a third threshold. 18. A method of providing indication when replacement of an interstitial glucose sensing element should be performed in connection with operating an infusion device operable to deliver insulin to a body of a user, the method comprising: determining, by a control module coupled to the interstitial glucose sensing element, a plurality of uncalibrated filtered measurements indicative of an interstitial fluid glucose level in the body of the user based on output signals from the interstitial glucose sensing element, wherein the output signals are influenced by the interstitial fluid glucose level in the body;obtaining, by the control module, a calibration factor for converting the plurality of uncalibrated filtered measurements to a plurality of calibrated sensor glucose values;for each respective filtered measurement of the subset: determining a second derivative metric associated with the respective filtered measurement of the subset based at least in part on a difference between a first derivative metric associated with the respective filtered measurement and the first derivative metric associated with the preceding filtered measurement of the subset, wherein the second derivative metric associated with a most recent filtered measurement of the subset comprises the greater of a difference between the first derivative metric associated with the most recent filtered measurement and the first derivative metric associated with the immediately preceding filtered measurement of the subset and an average magnitude of second derivative metric values associated with the subset;scaling the second derivative metric associated with the respective filtered measurement by the calibration factor to determine a respective noise metric associated with the respective filtered measurement of the subset;determining, by the control module, a number of high noise measurements during the monitoring period as a number of respective filtered measurements of the subset having an associated noise metric greater than a threshold value;determining, by the control module, a reliability metric for the monitoring period as a ratio of an average measurement value for the monitoring period to the number of high noise measurements during the monitoring period;determining, by the control module, an output measurement value indicative of the interstitial fluid glucose level based at least in part on the most recent measurement of the subset and at least one of the first derivative metric associated with the most recent measurement and the second derivative metric associated with the most recent measurement;transmitting, by a communications interface coupled to the control module, the output measurement value to the infusion device, wherein a delivery command for operating a motor of the infusion device to autonomously control delivery of the fluid to the user is determined based at least in part on the output measurement value and the calibration factor; andproviding, via an output interface, a user notification to replace the interstitial glucose sensing element when the reliability metric violates a first threshold. 19. The method of claim 18, further comprising determining a second number of consecutive monitoring periods having an associated reliability metric less than the first threshold when the reliability metric for the monitoring period is less than the first threshold, wherein providing the user notification comprises automatically providing the user notification when the second number of consecutive monitoring periods is greater than a second threshold.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (198)
Batina, William P.; White, Robert M., Acquisition circuit for cardiac pacer.
Schulman Joseph H. ; Lucisano Joseph Y. ; Shah Rajiv ; Byers Charles L. ; Pendo Shaun M., Alumina insulation for coating implantable components and other microminiature devices.
Tune Joel (Antioch IL) Anderson Robert L. (Boulder CO) Blankenship Larry (Boulder CO) Colesworthy ; III Daniel C. (Boulder CO) Heim Warren P. (Boulder CO) Miller ; III Scott A. (Boulder CO) Sherman B, Ambulatory infusion pump.
Coutr James E. (Concord MA) Griffin Wayne P. (Dracut MA) Crisler Charles M. (Windham NH), An infusion management and pumping system having an alarm handling system.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S. ; Friedman Keith A. ; Colman Fredric C., Analyte monitoring device and methods of use.
Steil, Garry M.; Rebrin, Kerstin; Goode, Jr., Paul V.; Mastrototaro, John J.; Purvis, Richard E.; Van Antwerp, William P.; Shin, John J.; Talbot, Cary D., Closed loop system for controlling insulin infusion.
Prestele Karl (Erlangen DEX) Franetzki Manfred (Uttenreuth DEX) Reif Erich (Erlangen DEX), Device for the infusion of fluids into the human or animal body.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Electrochemical analyte.
James Say ; Michael F. Tomasco ; Adam Heller ; Yoram Gal IL; Behrad Aria ; Ephraim Heller ; Phillip John Plante ; Mark S. Vreeke, Electrochemical analyte sensor.
Gibson, Scott R.; Shah, Rajiv; Chernoff, Edward; Byers, Charles, Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat Zu Lubeck ; Klinik Fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat zu Lubeck ; Klinik fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Flex circuit connector.
Dempsey Michael K. (Acton MA) Kotfila Mark S. (Chelmsford MA) Snyder Robert J. (Westford MA), Flexible patient monitoring system featuring a multiport transmitter.
Yap, Darren Y. K.; Gulati, Poonam; Kovelman, Paul H.; Van Antwerp, William P.; Enegren, Bradley J.; Geismar, Eric P.; Hudak, Philip J.; McConnell, Susan; Moberg, Sheldon B., Fluid reservoir piston.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville R. (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Bever, Glucose monitoring system.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville Rey (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Beve, Glucose sensor assembly.
McIvor, K. Collin; Cabernoch, James L.; Branch, Kevin D.; Van Antwerp, Nannette M.; Halili, Edgardo C.; Mastrototaro, John J., Glucose sensor package system.
Allen Douglas J. (Indianapolis IN) Johnson Kirk W. (Indianapolis IN) Nevin Robert S. (Indianapolis IN), Hydrophilic polyurethane membranes for electrochemical glucose sensors.
Schulman Joseph H. ; Byers Charles L. ; Adomian Gerald E. ; Colvin Michael S., Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces.
Wilson George S. (Lawrence KS) Bindra Dilbir S. (Lawrence KS) Hill Brian S. (Lawrence KS) Thevenot Daniel R. (Paris Cedex FRX) Sternberg Robert (Thiais FRX) Reach Gerard (Paris Cedex KS FRX) Zhang Ya, Implantable glucose sensor.
Meadows, Paul M.; Mann, Carla M.; Tsukamoto, Hisashi; Chen, Joey, Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries.
Gargano Diane A. ; Flachbart Eric J. ; Cowen Barry ; Duh Monica ; Rudser ; Jr. John L. ; Zhen Ken ; Noble Lynn ; Warhurst Julian ; Pedraza Luis, Infusion pump for at least one syringe.
Coutre James E. (114 Stone Root La. Concord MA 01742) Griffin Wayne P. (55 Surrey La. Dracut MA 01826) Crisler Charles M. (10 Sunridge Rd. Windham NH 03087), Infusion pump management system for suggesting an adapted course of therapy.
Causey ; III James D. (Simi Valley CA) Schloss Harold C. (Los Angeles CA) Snell Jeffery D. (Northridge CA), Interactive programming and diagnostic system for use with implantable pacemaker.
Say, James L.; Sakslund, Henning; Tomasco, Michael F.; Audett, Jay D.; Cho, Hyun; Yamasaki, Duane O.; Heller, Adam, Mass transport limited in vivo analyte sensor.
Castellano Thomas P. (Beverly Hills CA) Schumacher Robert (Beverly Hills CA), Medication delivery device with a microprocessor and characteristic monitor.
Colman Fredric C. (Granada Hills CA) Purvis Richard E. (Glendale CA), Medication infusion system having optical motion sensor to detect drive mechanism malfunction.
Peterson Bruce A. (Milwaukie OR) Hogard Michael E. (Oregon City OR) Johnson Harley D. (Portland OR) Kelly Thomas D. (Portland OR) Long Jean M. (Portland OR) Preston ; Jr. William G. (Portland OR), Method and apparatus for kidney dialysis.
Joseph H. Schulman ; Joseph Y. Lucisano ; Rajiv Shah ; Charles L. Byers ; Shaun M. Pendo, Method of applying insulation for coating implantable components and other microminiature devices.
Feldman, Benjamin J.; Heller, Adam; Heller, Ephraim; Mao, Fei; Vivolo, Joseph A.; Funderburk, Jeffery V.; Colman, Fredric C.; Krishnan, Rajesh, Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator.
Moberg, Sheldon B.; Causey, III, James D.; Bare, Rex O.; Scherer, Andrew J.; Sargent, Bradley J., Methods, apparatuses, and uses for infusion pump fluid pressure and force detection.
Sheldon B. Moberg ; James D. Causey, III ; Rex O. Bare ; Andrew J. Scherer ; Bradley J. Sargent, Methods, apparatuses, and uses for infusion pump fluid pressure and force detection.
Brown Stephen J. ; Jensen Erik K., On-line health education and feedback system using motivational driver profile coding and automated content fulfillment.
Roizen Michael (Chicago IL) Turcotte ; II William E. (Oak Park IL) Pfisterer Richard E. (Arlington Heights IL), Portable medical interactive test selector having plug-in replaceable memory.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Process for producing an electrochemical biosensor.
Livingston John H. (Los Angeles CA) Frye Ward K. (San Luis Obispo CA) Field Jeffrey F. (Northridge CA), Proctective case for a medication infusion pump.
Sancoff Gregory E. (Leucadia CA) McWilliams Mark (San Diego CA) Barr Howard S. (Escondido CA) Cordner ; Jr. Edward T. (Carlsbad CA) Barton Russell C. (Monrovia CA), Programmable infusion system.
Shin, John J.; Holtzclaw, Kris R.; Dangui, Nandita D.; Kanderian, Jr., Sami; Mastrototaro, John J.; Hong, Peter I., Real time self-adjusting calibration algorithm.
Langen Pauline A. (Simsbury CT) Katz Jeffrey S. (West Hartford CT) Dempsey Gayle (Needham MA) Pompano James (East Haven CT), Remote monitoring of high-risk patients using artificial intelligence.
Epstein Paul (Brookline MA) Petschek Harry (Lexington MA) LaWhite Eric (South Royalton VT) Strohl Clair (Norfolk MA) Coyne Henry (Framington MA) Kaleskas Edward (Jefferson MA) Adaniya George (Swampsc, Remotely programmable infusion system.
Lundquist Ingemar H. (Pebble Beach CA) Tarczy-Hornoch Zoltan (Berkeley CA) Kardos Thomas J. (Laguna Beach CA), Retroperfusion and retroinfusion control apparatus, system and method.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Nason Clyde K. (25745 N. Player Dr. Valencia CA 91355) Culp Gordon W. (13832 Haynes St. Van Nuys CA 91401), Solenoid drive apparatus for an external infusion pump.
Starkweather, Timothy J.; Lebel, Ronald J.; Shah, Rajiv; Miller, Michael E., System and method for providing closed loop infusion formulation delivery.
Aoki Thomas T. (1021 El Sur Way Sacramento CA 95825), System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof.
Tacklind Christopher A. (Palo Alto CA) Sanders Matthew H. (Los Altos Hills CA) Walne Geoffrey B. (Atherton CA), System for monitoring and reporting medical measurements.
Blomquist Michael L. (Coon Rapids MN) Peterson Thomas L. (Shoreview MN), Systems and methods for operating ambulatory medical devices such as drug delivery devices.
Kamath, Apurv Ullas; Brauker, James H.; Mahalingam, Aarthi; Li, Ying, Systems and methods for replacing signal artifacts in a glucose sensor data stream.
Mann, Alfred E.; Purvis, Richard E.; Mastrototaro, John J.; Causey, James D.; Henke, James; Hong, Peter; Livingston, John H.; Hague, Clifford W.; Hite, Brad T., Telemetered characteristic monitor system and method of using the same.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Transcutaneous sensor insertion set.
Gerety, Eugene P.; Strempski, Richard A.; Sardi, Stephen G., Two-dimensional printed code for storing biometric information and integrated off-line apparatus for reading same.
Carter,Scott J.; Flanders,Edward L.; Hannah,Stephen E., Wireless LAN architecture for integrated time-critical and non-time-critical services within medical facilities.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.